Breaking News:Dangerous Delays: What Washington State (Re)Teaches Us About Cash and Cannabis Store Robberies [REPORT]

Feature: Ibogaine Forum 2010 -- Mourning the Movement's "Tare," Celebrating New Hopes for Research and Development

special to Drug War Chronicle by Doug Greene

Over a cold President's Day weekend, dozens of researchers, providers and activists converged on the Yippie Museum Cafe for the Ibogaine Forum 2010, the annual conference about the controversial African rainforest addiction interrupter. This year's event was held just downstairs from the lair of conference organizer, Global Marijuana March facilitator and Cures not Wars cofounder Dana Beal (who remains free on bail from his October 1st bust following last year's NORML conference). This year's Ibogaine Forum, like last year's, was streamed to hundreds of viewers.
Howard Lotsof
Tabernanthe iboga has been used for several centuries by practitioners of the Bwiti religion in equatorial Africa. But it wasn't until June 1962 that its principal alkaloid's effects on opiate dependence were discovered. Howard Lotsof (then a Fairleigh Dickinson University dropout with a heroin habit) took a dose that a chemist friend gave him, and after a 36 hour trip full of Freudian imagery, discovered that he didn't want to cop heroin anymore. That random trip started Lotsof on his life's work and led to thousands of people participating in "a vast uncontrolled experiment" (in the words of writer Brian Vastag) to treat drug dependence. However, its status as a Schedule I controlled substance, long duration of action and intense psychological and physical effects have kept it outside of the medical mainstream.

Ibogaine has been receiving more media attention and public interest in the past few months. It was featured in the plot of an episode of "Law & Order Special Victims Unit" in November and in "I'm Dangerous with Love," Michel Negroponte's new documentary about New York based on underground provider Dimitri Mobengo Mugianis. Although the buzz about ibogaine has been slowly building for decades, efforts to develop ibogaine as a medication for drug dependence in the United States have been stalled since 1995, when a Food and Drug Administration (FDA) approved Phase I study in humans was halted after the National Institute of Drug Abuse (NIDA) spent $2,000,000 in pre-clinical and animal testing, due to financial issues and disputes among the study sponsors.

That may be about to change, since Dr. Walter Ling, the Director of UCLA's Integrated Substance Abuse Programs, has allegedly undertaken a review of current ibogaine research for NIDA. Dr. Ling's web page states that he is a consultant to NIDA.

According to conference presenter Dr. Anwar Jeewa, co-director of the Minds Alive life rehabilitation and treatment center in Durban, South Africa, he met Ling at Schering-Plough's launch of Suboxone in Durban on Feb. 2, where Jeewa asked Ling if he knew about ibogaine. Ling admitted that he did, having received many phone calls from Lotsof, but was not aware of the amount of treatment providers and published research. He then revealed that NIDA had contracted with him to reassess ibogaine. Ling's research is overseen by Dr. Cecelia (Cece) McNamara Spitznas, PhD, of the Behavioral and Integrative Treatment Branch at NIDA's Division of Clinical Neuroscience and Behavioral Research. Adult treatment research is part of Dr. Spitznas' portfolio for NIDA.

However, according to David McCann, Associate Director (acting) of NIDA's Division of Pharmacotherapies and Medical Consequences of Drug Abuse, "nobody at NIDA knows anything about it. If [Ling] is in fact writing a review, he's apparently not doing it for NIDA."

Jeewa said this week that NIDA had not officially sanctioned Ling to reassess ibogaine, but had done so unofficially. Ling had not responded to requests for clarification by press time.

Despite that and other enormously positive news, conference attendees were still reeling from Lotsof's death on Jan. 31st after a long struggle with liver cancer. Lotsof was recognized as "[the] discoverer of ibogaine's anti-addictive effects, patient activist, president of the Dora Weiner Foundation and author of the Ibogaine Patient's Bill of Rights" last November, when the Drug Policy Alliance co-awarded him the Robert C. Randall Award for Achievement in the Field of Citizen Action at their biennial conference. (The video is here).

At Ibogaine Forum 2010, Lotsof was posthumously honored by a large number of presenters and attendees during Sunday's memorial. "Ibogaine-Rite of Passage" producer and director Ben De Loenen showed footage of Lotsof he took at last March's Lotsof tribute First Ibogaine Providers and Facilitators Conference, in which Lotsof called ibogaine "a magnificent tool and road to freedom over slavery" and expressed his belief that ibogaine would eventually be used successfully in drug treatment, in contrast to his pessimism at the end of the film. That conference also marked the founding of the International Federation of Ibogaine Providers.

Another presenter, NYU Langone Medical Center Associate Professor Ken Alper, pointed out that in addition to Lotsof's personal qualities, his work was directly responsible for NIDA's research into ibogaine, a slew of peer-reviewed publications and the First International Conference on Ibogaine, which was held in 1999. But perhaps Beal summed it up best when he told the audience the best way to memorialize Lotsof was to move ibogaine forward and help realize his dream.

The sheer diversity of the presenters, attendees and topics discussed would have heartened Lotsof. Among the attendees were Midge Potts, a Missouri US Senate candidate calling for ibogaine treatment as part of her platform, a nurse from New Jersey whose boyfriend was part of a Multidisciplinary Association for Psychedelic Studies (MAPS) long-term outcomes study on ibogaine's efficacy for treatment of opiate dependence at Pangea Biomedics in Playas De Tijuana, Mexico, and LEAP's Matthew Fogg.

Presenters included:

  • MAPS' John Harrison, discussing the preliminary results of their ibogaine study (of 20 participants, 10 were confirmed as still not using), a revised study protocol, ibogaine's potential in treating HIV, HTLV, depression, obsessive compulsive disorder and other personality disorders and "aftercare as an afterthought" among providers.
  • Robert Sisko of the Addiction Research Institute on efforts to produce ibogaine according to Good Manufacturing Practice for use in clinical trials and a proposed multinational study to have the FDA approve ibogaine for alleviation of opiate withdrawal symptoms.
  • San Francisco provider Krista Howard on tips for new treatment providers.
  • Sandra Karpetas of British Columbia's Iboga Therapy House and New Zealand activist and aspiring provider Marie Cotter on ibogaine's status in their countries (where it's not regulated, but also not officially legitimized for use), the need for further research, standardizing data from ibogaine therapists, defining best practices in ibogaine therapy, and the rationale for adopting language that defines ibogaine as a natural health product.

However, none of the ibogaine enthusiasts present believed that it was going to conquer the drug treatment world in the near future. The mainstream treatment establishment remains skeptical, if not outright hostile to ibogaine -- as witnessed by the comment of Dr. Herbert Kleber, director of the division on substance abuse at the New York State Psychiatric Institute at Columbia University in Lotsof's New York Times obituary, who cited a lack of controlled studies and a number of deaths to conclude that "it is [not] something that should be used in the absence of such evidence." Alper and others have attributed these deaths to factors such as cardiac risks that could have been detected by better screening and overdoses from taking opiates during or just after an ibogaine experience.

Naysayers like Kleber aside, with research, production techniques, initiates and providers experiencing rapid growth around the world, ibogaine's potential for transformation of the way drug dependence is viewed and treated seems boundless. The spirit of Lotsof, as the tare ("father" in the Fang language, which is spoken in Tabernanthe iboga's native equatorial Africa) of it all, must be pleased that so many believers are, as Krista Howard said at his memorial, "working together to finish this masterpiece, make it even more beautiful and legitimize it."

Permission to Reprint: This article is licensed under a modified Creative Commons Attribution license.
Looking for the easiest way to join the anti-drug war movement? You've found it!


have tried ibogaine a few times (to kick smack and just for kicks) and it didn't impress me too much. didn't help with the gear much (i found reducing on buprenorphine much more useful) and it mostly just gave me a headache. made me think too much, way too much.


I wa acquainted with Howard, but not with Fang, so when I read the headline, I thought it meant "tare" in the sense of "dead weight"!


Thank you for the great article. It makes me hopeful that ibogaine is moving forward.

Iboga Therapy

For more information on ibogaine please visit

Jean Boyd's picture

A natural Cure

Ibogaine is not really something that should be taken "just for kicks". Anyway, Ibogaine is a wonderful plant that serves many purposes. I view it as a plant that will help a person become better from whatever the problem is. Sugar, caffeine, cocaine, heroin, speed or alcohol. But then it goes beyond that purpose and adds to the person's spiritual growth. Howard Lotsoff states that over 15,000 people internationally have used Ibogaine. I wonder why the U.S. Government does not approve Ibogaine as other countries have.


The US does not want to accept this cure because the need for expensive AA drug houses will be put out of business. Why don't they think there are other ways they can make money and help people with Ibogaine.

Is it really fair to characterize Dr. Kleber as a "naysayer?"

I'm just sayin'... Caution and/or conservative viewpoints on the matter of establishing credible scientific evidence is not necessarily "hostile."

Clean since my visit to the Iboga House in Costa Rica.

I had a traditional Iboga ceremony with a 10th generation Shaman originally from Gabon. It got me off drugs and changed my life! It wasn't just the Iboga and Ibogaine that he used, it was the fact that he is a very powerful shaman who was able to communcate with the spirit of Iboga and that is what I believe made my treatment so successful. He was right next to me the whole time I was at his healing center. It was like I had my own personal Shaman for the 10 days that I was there. What an incredable experience. My friends saw the drastic change in me and wanted the same for themselves so I refered 5 of my friends to him and they had the same amazing results. Its been 8 months drug free for me and just under 6 months for 4 of my friends. It not only got me drug free but it changed my life for the better. I am now much more confident and successful in my everyday life. The center I went to was the Iboga House in Costa Rica. The Shaman was Moughenda Mickala. The staff that are there at the center are so nice and the food was awesome, too. Oh yeah and after the treatment they even took us (me and the three other people that were there at the time and one of the staff members) horse back riding, zip lining, swiming in the ocean, for a spiritual bath in a waterfall and we had massages and a clay body wrap. Single best experience in my life!

borden's picture

comment accidentally deleted

I accidentally deleted a comment from this post while getting rid of a bunch of comment spam. I think it referred to a site called "Iboga World."

David Borden, Executive Director the Drug Reform Coordination Network
Washington, DC

This is indeed great news for

This is indeed great news for the transformation of the respective field. With research, production techniques, unique initiates and providers experiencing unusual rapid growth around the world, it is pretty clear. Thanks a lot for sharing the updates. I would like to know more.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <i> <blockquote> <p> <address> <pre> <h1> <h2> <h3> <h4> <h5> <h6> <br> <b>

More information about formatting options

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, Vaping, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safer Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School